U.S. Department of Justice Office of Legislative Affairs

LYV INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces Live Nation Entertainment, Inc. Investors with Substantial Losses Have Opportunity to Lead the Live Nation Class Action Lawsuit

Retrieved on: 
Friday, August 4, 2023

), the Live Nation class action lawsuit charges Live Nation and certain of its top executive officers with violations of the Securities Exchange Act of 1934.

Key Points: 
  • ), the Live Nation class action lawsuit charges Live Nation and certain of its top executive officers with violations of the Securities Exchange Act of 1934.
  • Lead plaintiff motions for the Live Nation class action lawsuit must be filed with the court no later than October 3, 2023.
  • The lead plaintiff can select a law firm of its choice to litigate the Live Nation class action lawsuit.
  • An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Live Nation class action lawsuit.

Wicklander-Zulawski Partners with Learning Ninjas and The Law Enforcement Innovation Center to Bring Non-Confrontational Interviewing Techniques to Investigators

Retrieved on: 
Thursday, August 3, 2023

This online training course was created by The Law Enforcement Innovation Center (LEIC), an agency of the University of Tennessee Institute for Public Service.

Key Points: 
  • This online training course was created by The Law Enforcement Innovation Center (LEIC), an agency of the University of Tennessee Institute for Public Service.
  • The partnership between Wicklander-Zulawski and Learning Ninjas brings together two industry powerhouses, each known for their expertise in their respective fields.
  • By leveraging their advanced technology and user-friendly interface, Learning Ninjas ensures that the training course is accessible and adaptable to law enforcement.
  • "We are excited to collaborate with Learning Ninjas to bring our expertise in non-confrontational interviewing techniques to a wider audience," said Dave Thompson, President of Wicklander-Zulawski.

Martin's Point Health Care Risk Adjustment Settlement

Retrieved on: 
Monday, July 31, 2023

PORTLAND, Maine, July 31, 2023 /PRNewswire/ -- Today, Martin's Point Health Care announced that it has agreed to a settlement with the U.S. Department of Justice (DOJ) to resolve an investigation related to Martin's Point's Risk Adjustment practices for the payment years 2016-2019.

Key Points: 
  • PORTLAND, Maine, July 31, 2023 /PRNewswire/ -- Today, Martin's Point Health Care announced that it has agreed to a settlement with the U.S. Department of Justice (DOJ) to resolve an investigation related to Martin's Point's Risk Adjustment practices for the payment years 2016-2019.
  • The settlement is not related to member care or the payment of member claims.
  • Martin's Point Health Care is committed to the integrity of our work, mission, and service to our patients and members.
  • Since 2019, Martin's Point has taken steps to strengthen and develop new Risk Adjustment processes.

INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Booz Allen Hamilton Holding Corporation’s Directors and Officers for Breach of Fiduciary Duties – BAH

Retrieved on: 
Friday, July 28, 2023

Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of Booz Allen Hamilton Holding Corporation (“Booz Allen”) (NYSE: BAH) breached their fiduciary duties to Booz Allen and its shareholders.

Key Points: 
  • Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of Booz Allen Hamilton Holding Corporation (“Booz Allen”) (NYSE: BAH) breached their fiduciary duties to Booz Allen and its shareholders.
  • If you are a Booz Allen shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982, or [email protected] .
  • Scott+Scott is investigating whether members of Booz Allen’s board of directors or senior management failed to manage Booz Allen in an acceptable manner, in breach of their fiduciary duties to Booz Allen, and whether Booz Allen and its shareholders have suffered damages as a result.
  • If you are a Booz Allen shareholder, you may have legal claims against Booz Allen’s directors and officers.

Sterling Bancorp Reports Second Quarter 2023 Financial Results

Retrieved on: 
Wednesday, July 26, 2023

(the “Bank”), today reported its unaudited financial results for the second quarter ended June 30, 2023.

Key Points: 
  • (the “Bank”), today reported its unaudited financial results for the second quarter ended June 30, 2023.
  • Net recoveries during the second quarter of 2023 were $(0.4) million compared to net charge offs of $6.4 million in the first quarter of 2023.
  • Net Interest Income and Net Interest Margin – Net interest income for the second quarter of 2023 was $16.2 million compared to $17.7 million for the first quarter of 2023 and $19.5 million for the second quarter of 2022.
  • The net interest margin of 2.64% for the second quarter of 2023 decreased from the net interest margin of 2.93% for the first quarter of 2023 and decreased from the net interest margin of 2.95% for the second quarter of 2022.

Exelixis, Inc. Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Teva Pharmaceuticals Development, Inc. and Teva Pharmaceuticals USA, Inc.

Retrieved on: 
Sunday, July 23, 2023

Exelixis, Inc. (Nasdaq: EXEL) today announced that it has entered into a Settlement and License Agreement (Agreement) with Teva Pharmaceuticals Development, Inc. and Teva Pharmaceuticals USA, Inc. (collectively Teva).

Key Points: 
  • Exelixis, Inc. (Nasdaq: EXEL) today announced that it has entered into a Settlement and License Agreement (Agreement) with Teva Pharmaceuticals Development, Inc. and Teva Pharmaceuticals USA, Inc. (collectively Teva).
  • This settlement resolves patent litigation brought by Exelixis in response to Teva’s Abbreviated New Drug Application (ANDA) seeking approval to market a generic version of CABOMETYX® (cabozantinib) tablets prior to the expiration of the applicable patents.
  • Additionally, in accordance with the Agreement, the parties will terminate all ongoing Hatch-Waxman litigation between Exelixis and Teva regarding CABOMETYX patents pending in the U.S. District Court for the District of Delaware.
  • The Agreement is confidential and subject to review by the U.S. Federal Trade Commission and the U.S. Department of Justice.

Booz Allen Hamilton Holding Corporation Pays Over $377 Million To Settle Whistleblower Fraud Allegations

Retrieved on: 
Friday, July 21, 2023

WASHINGTON, July 21, 2023 /PRNewswire/ -- The U.S. Department of Justice (DOJ) has entered into a settlement with Booz Allen Hamilton Holding Corporation (Booz Allen) to resolve a lawsuit that began seven years ago with the filing of a whistleblower complaint by a former employee.

Key Points: 
  • WASHINGTON, July 21, 2023 /PRNewswire/ -- The U.S. Department of Justice (DOJ) has entered into a settlement with Booz Allen Hamilton Holding Corporation (Booz Allen) to resolve a lawsuit that began seven years ago with the filing of a whistleblower complaint by a former employee.
  • The whistleblower, Sarah Feinberg, alleged that Booz Allen had been overcharging the federal government by knowingly presenting false claims for reimbursement.
  • Booz Allen agreed to pay the government $377,453,150 to settle the claims, originally filed by the whistleblower under the qui tam provisions of the False Claims Act.
  • In this case, the government awarded the whistleblower nearly $70 million.

Sterling Bancorp, Inc. Plea Agreement with DOJ Receives Final Court Approval

Retrieved on: 
Wednesday, July 19, 2023

Sterling Bancorp, Inc. (NASDAQ: SBT) (the “Company”), the holding company of Sterling Bank and Trust, F.S.B.

Key Points: 
  • Sterling Bancorp, Inc. (NASDAQ: SBT) (the “Company”), the holding company of Sterling Bank and Trust, F.S.B.
  • (the “Bank”), today announced that the United States District Court for the Eastern District of Michigan approved the Plea Agreement previously entered into by the Company with the U.S. Department of Justice, Criminal Division, Fraud Section (the “DOJ”).
  • The restitution amount will be administered by a special master to be appointed by the court.
  • The Company and the DOJ entered into the Plea Agreement on March 15, 2023, resolving the DOJ’s investigation focused on the Bank’s Advantage Loan Program and related issues.

Kloosterboer International Forwarding, Alaska Reefer Management Reach $9.5M Global Settlement with U.S. Customs and Border Protection, Justice Department; All Penalties in Bayside Railway Dispute Will Be Withdrawn

Retrieved on: 
Wednesday, July 19, 2023

Kloosterboer International Forwarding is a specialized freight forwarding business formed in Alaska, which arranges all supply chain services to transport conditioned seafood cargos from Dutch Harbor, Alaska -- the heart of the Bering Sea fisheries – to strategic markets and seafood buyers around the world. Together with its affiliate, Alaska Reefer Management, it contracts high quality, temperature-controlled logistics services from trusted partners on behalf of the Alaska seafood industry and their customers.

Key Points: 
  • The case had been in litigation at the U.S. District Court in Anchorage, Alaska.
  • KIF, ARM, CBP, and DOJ reached a global settlement, in which CBP agreed that all Notices of Penalty will be withdrawn and be of no force and effect.
  • We will continue providing reliable and cost-effective transportation and logistics to deliver high-quality, sustainable, Wild Caught Alaskan seafood products for our customers.
  • KIF and ARM are dedicated to serving their customers in the U.S. and around the world, enabling a prosperous future for the seafood industry.”

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL

Retrieved on: 
Wednesday, July 19, 2023

NEW YORK, July 19, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. (“Charles River” or the “Company”) (NYSE: CRL).

Key Points: 
  • NEW YORK, July 19, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. (“Charles River” or the “Company”) (NYSE: CRL).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether Charles River and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.